Atreca, Inc. Research and Development Expense of Revenue

Research and Development Expense of Revenue of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development Expense of Revenue for the quarter ending September 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development Expense of Revenue decreased by NaN%
  • Annual Research and Development Expense of Revenue for 2021 was 9206.7% (a 100.77% increase from previous year)
  • Annual Research and Development Expense of Revenue for 2020 was 4585.74% (a 78.82% increase from previous year)
  • Annual Research and Development Expense of Revenue for 2019 was 2564.48% (a -24.2% decrease from previous year)
  • Twelve month Research and Development Expense of Revenue ending September 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Research and Development Expense of Revenue decreased by NaN% year-over-year
Trailing Research and Development Expense of Revenue for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
0.0% 0.0% 4811.06% 0.0%
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development Expense of Revenue of Atreca, Inc.

Most recent Research and Development Expense of Revenueof BCEL including historical data for past 10 years.

Interactive Chart of Research and Development Expense of Revenue of Atreca, Inc.

Atreca, Inc. Research and Development Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0% 0.0% 2275.2%
2021 0.0% 11848.73% 5454.44% 5345.35% 9206.7%
2020 4603.01% 4761.47% 3518.61% 6151.52% 4585.74%
2019 4340.12% 0.0% 0.0% 0.0% 2564.48%
2018 0.0% 0.0% 3383.25%
2017 1376.85%

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology